Public consultation on the use of a GMO in a clinical trial

The Federal Agency for Medicines and Health Products and the Federal Public Service Health, Food Chain Safety and Environment inform the public about a clinical trial with a vaccine consisting of a genetically modified organism from the firm Laboratorios HIPRA used to fight against swine pleuropneumonia.

See other languages (french or Dutch)






Last updated on 05/03/2012